Clinical Trial Update: PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis [Phase 3]

View source ↗

Summary

The PRE-EMPT Phase 3 trial evaluating prospective management of premature atherosclerosis is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Snippet

Sponsor: Duke University | Conditions: Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression | Phase 3 | Status: NOT_YET_RECRUITING